KEYSTONE, COLO. — A multidisciplinary position statement on aspirin for primary prevention of cardiovascular disease events in diabetic patients raises more questions than it answers, especially with regard to the appropriate course of action in adults with type 1 diabetes.
via www.familypracticenews.com
Also of interest that they "urged physicians to loosen up and individualize their hemoglobin A1c targets"
Comments